News
Market and company headlines
ORCLAll
Loading
08:00Today3 Stories
Brokers Suggest Investing in Oracle (ORCL): Read This Before Placing a Bet
Based on the average brokerage recommendation (ABR), Oracle (ORCL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Here is What to Know Beyond Why Oracle Corporation (ORCL) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Oracle (ORCL). This makes it worthwhile to examine what the stock has in store.
Alliance Announces Official Oracle NetSuite Partnership & Appoints Stephen Rafferty as Director in the NetSuite Practice
Alliance, a national consulting firm specializing in solutions for the Office of the CFO, is proud to announce its official partnership with Oracle NetSuite, a leading cloud-based enterprise resource planning (ERP) platform. The announcement marks a significant milestone in Alliance's continued expansion of its Business Systems & Transformation capabilities and its commitment to helping organizations modernize financial operations, improve efficiency, and support sustainable growth.
07:00Today2 Stories
Oracle (ORCL) Unveils Deep Trust AI Architecture For Enterprise Governance
Oracle (NYSE:ORCL) introduced its Deep Trust AI Architecture, designed to embed security, privacy, and controls directly into AI systems. The company expanded its Autonomous AI Lakehouse with a Business Semantic Layer, Apache Iceberg table support, and unified data governance. Oracle stated that the new framework focuses on trusted data workflows for AI driven analytics and decision making across enterprises. Beyond the Deep Trust AI Architecture and Autonomous AI Lakehouse updates, Oracle...
Oracle Bonds Are Sliding as AI Debt Worries Grow. At 62, She Discovers the “Safe” Side of Her 401(k) Can Lose Money Too
Oracle's bonds are now trading wider than the average junk-rated debt, and the fallout reaches further than most retirees realize. If you keep your "safe" money in a bond fund, there are three things worth checking before your next withdrawal.
04:00Today1 Story
14:00-21:00Yesterday2 Stories
Oracle CEO admits its software can take years to get running
Oracle is handing the slowest part of a rollout to software agents, and its CEO hinted at who may come out ahead first.
Barclays Still Sees 100% Upside for Oracle. Here’s How It Gets to $252
Key TakeawaysBarclays repeated its Overweight rating and $252 price target on Oracle on Oct. 26.
09:00-12:00Yesterday2 Stories
Nvidia May Be Bankrolling More Than Chips in Oracle’s AI Expansion
TD Cowen says Nvidia may be helping finance Oracle’s data center push, potentially protecting chip demand while taking on additional financial risk.
Oracle Could Have a Massive AI Opportunity. Here’s Where the Stock Could Go
Oracle just posted its strongest cloud growth in years, yet the stock sits near a 52-week low while Wall Street debates whether the debt-fueled AI buildout is a trap or a once-in-a-decade entry point.
08:00Yesterday5 Stories
Oracle Advances Outcome-Driven AI Across Fusion Applications
Oracle AI World -- Oracle today announced new AI innovations across Oracle Fusion Cloud Applications. With new Oracle Fusion Agentic Applications powered by Oracle Fusion Claw, organizations can complete highly complex work economically and at scale across finance, HR, supply chain, sales, and service. To connect business objectives with execution, new AI experiences, including Oracle Fusion Companion and Oracle Fusion Agentic Home, enable users to define what they want to accomplish, delegate w
Oracle Introduces AI Agent-Ready Fusion Applications Setup and Configuration to Speed Implementations
Oracle AI World -- Oracle today announced the Oracle Fusion Setup and Configuration Registry (FSCR), a public Git repository that makes Oracle Fusion Cloud Applications setup and configuration machine-readable and executable by AI agents. Built and continuously maintained by Oracle, FSCR captures Oracle product expertise and best practices as reusable AI skills that enable agents to plan, execute, test, and validate setup and configuration directly in Oracle Fusion Applications. By automating mu
12:00Oct 251 Story
03:00-07:00Oct 242 Stories
Oracle (ORCL) Commits $1 Billion To Partner AI Growth
Oracle (NYSE:ORCL) announced a multi year, $1b investment program to support partner AI solution development and commercialization. The company is expanding Oracle Marketplace globally, widening access and purchasing options for cloud applications and partner offerings. Oracle introduced new agentic AI platforms and HR and industry focused AI applications aimed at automating complex enterprise workflows. Oracle's $1b partner AI program and new agentic AI applications are only part of the...
BE Stock Sees Worst Single-Day Fall In 3 Months — Jefferies Trims Price Target, Flags Lack Of Updates On Its Largest Opportunity With Oracle
According to TheFly, Jefferies analyst Julien Dumoulin-Smith lowered the firm's price target on Bloom Energy to $242 from $289 while maintaining a ‘Hold’ rating on the shares.
09:00-11:00Oct 232 Stories
Goldman Sachs Maintains Buy on Oracle, Lowers Price Target to $206
Goldman Sachs analyst Kash Rangan maintains Oracle (NYSE:ORCL) with a Buy and lowers the price target from $240 to $206.
Dan Ives Calls AI Sell-Off ‘SaaS Apocalypse 2.0,’ Says Oracle Is ‘In The Toughest Spot’
Ives said the industry is in year three of an eight to 10 year “Vegas Strip 1955”-type build out during an interview with Bloomberg.
08:00Oct 233 Stories
Prediction: Oracle Could Become a Much Bigger AI Winner Than Investors Expect
Oracle's stock has cratered 32% this year even as its cloud business posted explosive growth and locked in hundreds of billions in future contracts. Here is why the market may be pricing this AI infrastructure giant at a historic discount.
Oracle Announces $1 Billion Investment to Accelerate Partner Growth and AI-Driven Modernization for Customers
Oracle AI World -- Oracle today announced a $1 billion commitment to its partner ecosystem to help partners capitalize on customer demand for AI-powered solutions and services.
Oracle Expands Marketplace to Unlock New Partner Growth Opportunities
16:00-19:00Oct 222 Stories
Oracle (ORCL) Stock Looks Cheap As Shares Fell 55%
Oracle has seen its share price fall sharply over the past year, and that slide is prompting a fresh look at whether the current market value is still backed by the cash the business can generate. With the stock under pressure just as its cloud and AI ambitions require heavy spending, the key issue is how those future cash flows compare with today's price. Over the past 12 months, Oracle's stock has dropped 54.6%, which puts the spotlight on whether the recent selloff has moved the market...
Oracle (ORCL) Falls More Steeply Than Broader Market: What Investors Need to Know
Oracle (ORCL) closed at $125.51 in the latest trading session, marking a -2.8% move from the prior day.
11:00-16:00Oct 222 Stories
Oracle Is Down More Than a Third in 2026 Even as TD Cowen Flags Possible Nvidia Support. Here’s Where the Stock Could Go by 2031
Key Stats for Oracle StockCurrent Price: $129. 13Target Price (Mid): ~$430Street Target: ~$237Potential Total Return: ~233%Annualized IRR: ~30% / year__Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)__ >>> What Happened?Oracle (ORCL) may be getting help from one of its biggest partners.
Could Oracle Actually Achieve 120% Upside? Or Is Cantor Fitzgerald Totally Wrong?
Key TakeawaysOracle stock has lost 53% over the past year, and Cantor Fitzgerald reiterated its Overweight rating and $284 target on Oct. 22, 120% up from yesterday’s close.
10:00Oct 222 Stories
Oracle Investor Day to Focus on OCI Capacity Ramp, Applications Growth, RBC Says
Oracle's (ORCL) investor day is expected to provide further visibility on Oracle Cloud Infrastructur
Where Will Oracle Stock Be in 2029?
Oracle could go on a solid bull run over the next three years due to a potential acceleration in earnings growth.
07:00-10:00Oct 222 Stories
Oracle Stock Was Caught In the AI Debt Selloff. Wall Street Says That’s a Mistake.
Oracle has faced mounting concerns about funding its artificial-intelligence buildout.
Oracle Vs. Microsoft: How The Wildcard AI Spender Plans to Disrupt
Oracle is selling stock, piling on debt, and leaning on customer prepayments to go toe-to-toe with the richest company in cloud computing. Whether that funding gamble holds together may determine who controls the next wave of AI infrastructure.
17:00-22:00Oct 212 Stories
10:00-15:00Oct 212 Stories
Salesforce (CRM) vs Oracle (ORCL): Which Is a Better Stock to Buy?
Salesforce, Inc. (NYSE:CRM) closed at $242.45 on October 19. The stock returned 30.2% over the last 6 months, compared with an 11.6% return for the Insider Monkey Billionaire Index and 8.7% for the State Street SPDR S&P 500 ETF Trust. Oracle Corporation (NYSE:ORCL) closed at $129.59 the same day and has gone the other way, shedding more than […]
Oracle’s Growth to Valuation Mismatch is Less and Less Compelling
Oracle's cloud backlog is surging past $664 billion while free cash flow sits deep in negative territory, and the CFO refused to name a date when that flips. Something has to give, and figuring out which side breaks first changes everything about this stock.
08:00-10:00Oct 216 Stories
AI Cloud Stocks Rise as Musk Calls Overcapacity Talk ‘Ridiculous’: Nebius and CoreWeave Gain 3%, Oracle Edges Higher
Elon Musk spent last week spooking AI cloud investors with a single word, then reversed course entirely on a SpaceX earnings call, and now Nebius and CoreWeave shares are racing to recover ground while one critical market signal holds the key to whether this bounce lasts.
TD Cowen Thinks Nvidia Is Helping Oracle Get Its Data Centers Financed
Oracle is burning through cash faster than it earns revenue, its credit rating sits one notch above junk, and a TD Cowen analyst now suspects its biggest chip supplier may be quietly backstopping the whole expansion.
07:00Oct 212 Stories
Oracle vs. Microsoft: Which Is the Better AI Cloud Stock to Own for the Next 5 Years?
Oracle's AI-related growth is hard to ignore. But Microsoft's stronger cash flow could make it the better stock to own over the next five years.
Oracle AI Agent Studio for Industry Applications Helps Accelerate Business Outcomes
Oracle today announced Oracle AI Agent Studio1 for Industry Applications, a no-code and low-code environment for creating, testing, orchestrating, deploying, and managing AI agents and workflows for industry-specific business processes. Building on Oracle AI Agent Studio for Fusion Applications, the new offering enables customers and partners to build and extend agents, leveraging existing application data, tools, and business processes, and embed these agents into daily workflows to reduce manu
04:00-06:00Oct 212 Stories
AstraZeneca and Oracle collaborate to test AI in clinical trial recruitment
The initiative aims to address recruitment hurdles by enabling healthcare providers to spot suitable individuals with ease.
Market Chatter: Oracle Chairman Larry Ellison Borrowed Billions to Finance Son's Warner Bros. Discovery Acquisition
Oracle (ORCL) Executive Chairman Larry Ellison borrowed billions of dollars from Citigroup (C), HSBC
01:00Oct 211 Story
15:00-21:00Oct 202 Stories
12:00Oct 202 Stories
Oracle Just Dropped 12% in a Month. Is It Time to Sell, or Load Up?
Key TakeawaysOracle stock fell 12% in the past month (through Monday’s close), mostly on three days of AI debt fears, while the S&P 500 rose 0. 6%.
Oracle (ORCL) Expands Its AI Healthcare Push With A New Drugmaker Partnership
Oracle (NYSE: ORCL) and AstraZeneca announced a partnership to advance AI-enabled healthcare solutions focused on real-world data and clinical research. The collaboration aims to improve identification of eligible patients for clinical trials and to speed up evidence generation from real-world datasets. Both companies plan to link research outputs directly into care delivery workflows across several therapeutic areas, including chronic and complex diseases. The Oracle and AstraZeneca...
09:00-11:00Oct 202 Stories
What Is Oracle’s (ORCL) Economic Moat, and Is It Widening or Narrowing?
A moat is usually tested by asking what a customer would have to do to leave. For Oracle Corporation (NYSE:ORCL) that question has two answers now, and they point in opposite directions. The stock closed at $129.59 on October 19. It has returned -27% over the last 6 months, compared to an 11.6% return for […]
Oracle (ORCL): Can Rival Clouds Become Its Best Database Sales Channel?
Oracle Corporation (NYSE:ORCL) can sell more database services without moving every customer’s applications to its own cloud. As enterprises connect artificial intelligence to existing data, placing databases beside applications on rival platforms removes a migration obstacle. Management reported 353% multicloud database revenue growth in fiscal 2027’s first quarter, alongside 180% customer growth. Oracle Corporation (NYSE:ORCL) […]
08:00Oct 202 Stories
CoreWeave Falls 4% as HSBC Reiterates Bearish Call on Debt Risk; Nebius Drops 5%, Oracle Holds Steady
HSBC is doubling down on its bearish call against CoreWeave just as credit markets start flashing distress signals, and the selloff is spreading to a rival that was never even named in the note.
Oracle Bonds Face Downgrade Risks As AI Trade Fizzles Across Tech Sector
Key Stats for Oracle StockPrice change for Oracle stock in last 6 months: -27%$ORCL Stock Price as of Oct. 19: $13052-Week High: $287$ORCL Stock Price Target: $237What Happened?Oracle (ORCL:NYSE) is facing fresh worries in the bond market.
06:00-08:00Oct 202 Stories
Oracle, AstraZeneca Explore AI To Tackle Clinical-Trial Recruitment Challenge
Oracle and AstraZeneca plan to explore AI applications to improve clinical-trial recruitment, accelerate evidence generation and bring research insights into everyday care.
AstraZeneca and Oracle Launch AI Partnership to Improve Clinical Trials and Patient Care
AstraZeneca (NYSE:AZN) has entered into a partnership with Oracle (NYSE:ORCL) to investigate how artificial intelligence and cloud-based technology can improve clinical research and healthcare processes across several international markets. The agreement will combine AstraZeneca’s pharmaceutical research activities with Oracle’s AI, cloud computing and data management systems, focusing on practical applications within clinical development and patient care.
02:00-06:00Oct 202 Stories
Stellar Cyber Security Operations Solutions Now Available on Oracle Marketplace
SAN JOSE, Calif., October 20, 2026--Stellar Cyber, a leading provider of security operations solutions and an Oracle partner, today announced that Stellar Cyber Security Operations Platform, Stellar Cyber Open XDR SecOps Platform, and Stellar Cyber Next-Generation SIEM are now available on Oracle Marketplace.
AstraZeneca Partners With Oracle to Refine Clinical Research With AI
AstraZeneca is teaming up with Oracle to refine clinical research, in the latest artificial-intelligence partnership in the pharmaceutical industry.
